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Whereas chromosomal translocations are common
pathogenetic events in cancer, mechanisms that
promote them are poorly understood. To elucidate
translocation mechanisms in mammalian cells, we
developed high-throughput, genome-wide translo-
cation sequencing (HTGTS). We employed HTGTS
to identify tens of thousands of independent translo-
cation junctions involving fixed I-SceImeganuclease-
generated DNA double-strand breaks (DSBs) within
the c-myc oncogene or IgH locus of B lymphocytes
induced for activation-induced cytidine deaminase
(AID)-dependent IgH class switching. DSBs translo-
cated widely across the genome but were preferen-
tially targeted to transcribed chromosomal regions.
Additionally, numerous AID-dependent and AID-
independent hot spots were targeted, with the latter
comprisingmainly cryptic I-SceI targets.Comparison
of translocation junctions with genome-wide nuclear
run-ons revealed amarked associationbetween tran-
scription start sites and translocation targeting. The
majority of translocation junctions were formed via
end-joiningwith shortmicrohomologies. Our findings
have implications for diverse fields, including gene
therapy and cancer genomics.INTRODUCTION
Recurrent oncogenic translocations are common in hematopoi-
etic malignancies including lymphomas (Ku¨ppers and Dalla-
Favera, 2001) and also occur frequently in solid tumors suchas prostate and lung cancers (Shaffer and Pandolfi, 2006).
DNA double-strand breaks (DSBs) are common intermediates
of these genomic aberrations (Stratton et al., 2009). DSBs are
generated by normal metabolic processes, by genotoxic agents
including some cancer therapeutics, and by V(D)J and immuno-
globulin (Ig) heavy (H) chain (IgH) class switch recombination
(CSR) in lymphocytes (Zhang et al., 2010). Highly conserved
pathways repair DSBs to preserve genome integrity (Lieber,
2010). Nevertheless, repair can fail, resulting in unresolved
DSBs and translocations. Recurrent translocations in tumors
usually arise as low-frequency events that are selected during
oncogenesis. However, other factors influence the appearance
of recurrent translocations including chromosomal location of
oncogenes (Gostissa et al., 2009). Chromosomal environment
likely affects translocation frequency by influencing mechanistic
factors, including DSB frequency at translocation targets,
factors that contribute to juxtaposition of broken loci for joining,
and mechanisms that circumvent repair functions that promote
intrachromosomal DSB joining (Zhang et al., 2010).
IgH CSR is initiated by DSBs that result from transcription-tar-
geted AID-cytidine deamination activity within IgH switch (S)
regions that lie just 50 of various sets of CH exons. DSBs within
the donor Sm region and a downstream acceptor S region are
fused via end-joining to complete CSR and allow expression of
a different antibody class (Chaudhuri et al., 2007). Clonal trans-
locations in human and mouse B cell lymphomas often involve
IgH S regions and an oncogene, such as c-myc (Ku¨ppers and
Dalla-Favera, 2001; Gostissa et al., 2011). In this regard, AID-
generated IgH S region DSBs directly participate in transloca-
tions to c-myc and other genes (Franco et al., 2006; Ramiro
et al., 2006; Wang et al., 2009). Through its role in somatic hyper-
mutation (SHM) of IgH and Ig light (IgL) variable region exons,
AID theoretically might generate lower frequency DSBs in Ig
loci that serve as translocation intermediates (Liu and Schatz,
2009). In addition, AID mutates many non-Ig genes in activatedCell 147, 107–119, September 30, 2011 ª2011 Elsevier Inc. 107
B cells at far lower levels than Ig genes (Liu et al., 2008); such off-
target AID activity alsomay contribute to translocations of non-Ig
genes (Robbiani et al., 2008). Indeed, AID even has been sug-
gested to initiate lesions leading to translocations in nonlym-
phoid cancers, including prostate cancer (Lin et al., 2009).
However, potential roles of AID in generating DSBs genome-
wide have not been addressed. In this regard, other sources of
translocation-initiating DSBs could include intrinsic factors,
such as oxidative metabolism, replication stress, and chromo-
some fragile sites, or extrinsic factors such as ionizing radiation
or chemotherapeutics (Zhang et al., 2010).
DSBs lead to damage response foci formation over 100 kb or
larger flanking regions, promoting DSB joining and suppressing
translocations (Zhang et al., 2010; Nussenzweig and Nussenz-
weig, 2010). IgH class switching in activated B cells can be
mediated by yeast I-SceI endonuclease-generated DSBs
without AID or S regions, suggesting general mechanisms
promote efficient intrachromosomal DSB joining over at least
100 kb (Zarrin et al., 2007). In somatic cells, classical nonhomol-
ogous end-joining (C-NHEJ) repairs many DSBs (Zhang et al.,
2010). C-NHEJ suppresses translocations by preferentially
joining DSBs intrachromosomally (Ferguson et al., 2000). Defi-
ciency for C-NHEJ leads to frequent translocations, demon-
strating that other pathways fuse DSBs into translocations
(Zhang et al., 2010). Correspondingly, an alternative end-joining
pathway (A-EJ), that prefers ends with short microhomologies
(MHs), supports CSR in the absence of C-NHEJ (Yan et al.,
2007) and joins CSR DSBs to other DSBs to generate transloca-
tions (Zhang et al., 2010). Indeed, C-NHEJ suppresses p53-
deficient lymphomas with recurrent IgH/c-myc translocations
catalyzed by A-EJ (Zhu et al., 2002). Various evidence suggests
that A-EJ may be translocation prone (e.g., Simsek and Jasin,
2010).
The mammalian nucleus is occupied by nonrandomly posi-
tioned genes and chromosomes (Meaburn et al., 2007). Fusion
of DSBs to generate translocations requires physical proximity;
thus, spatial disposition of chromosomes might impact translo-
cation patterns (Zhang et al., 2010). Cytogenetic studies re-
vealed that certain loci involved in oncogenic translocations
are spatially proximal (Meaburn et al., 2007). Studies of recurrent
translocations in mouse B cell lymphomas suggested that
aspects of particular chromosomal regions, as opposed to
broader territories, might promote proximity and influence trans-
location frequency (Wang et al., 2009). Nonrandom position of
genes and chromosomes in the nucleus led to two general
models for translocation initiation. ‘‘Contact-first’’ poses translo-
cations to be restricted to proximally positioned chromosomal
regions, whereas ‘‘breakage-first’’ poses that distant DSBs
can be juxtaposed (Meaburn et al., 2007). In-depth evaluation
of how chromosomal organization influences translocations
requires a genome-wide approach.
To elucidate translocation mechanisms, we developed
approaches that identify genome-wide translocations arising
from a specific DSB in vivo. Our studies isolate large numbers
of translocations from primary B cells, which were activated for
CSR, and provide a comprehensive analysis of the relationships
among particular classes of DSBs, transcription, chromosome
domains, and translocation events.108 Cell 147, 107–119, September 30, 2011 ª2011 Elsevier Inc.RESULTS
Development of High-Throughput Genomic
Translocation Sequencing
We developed high-throughput genomic translocation (HTGTS)
to isolate junctions between a chromosomal DSB introduced
at a fixed site and other sequences genome-wide. Such junc-
tions, other than those involving breaksite resection, mostly
should result from end-joining of introduced DSBs to other
genomic DSBs. Thus, HTGTS will identify other genomic DSBs
capable of joining to the test DSBs. With HTGTS, we isolated
from primary mouse B cells junctions that fused IgH or c-myc
DSBs to sequences distributed widely across the genome
(Figures 1A and 1B). We chose c-myc and IgH as targets
because they participate in recurrent oncogenic transloca-
tions in B cell lymphomas. To generate c-myc- or IgH-specific
DSBs, we employed an 18 bp canonical I-SceI meganuclease
target sequence, which is absent in mouse genomes (Jasin,
1996). One c-myc target was a cassette with 25 tandem I-SceI
sites, to increase cutting efficiency, within c-myc intron 1 on
chromosome (chr)15 (termed c-myc25xI-SceI; Figure 1C; Wang
et al., 2009). For comparison, we employed an allele with a single
I-SceI site in the same position (termed c-myc1xI-SceI) (Figure 1C;
see Figures S1A–S1C available online). For IgH, we employed an
allele with two I-SceI sites in place of endogenous Sg1 (termed
DSg12xI-SceI) on chr12 (Zarrin et al., 2007). As a cellular model,
we used primary splenic B cells activated in culture with
aCD40 plus IL4 to induce AID, transcription, DSBs and CSR at
Sg1 (IgG1) and S 3(IgE), during days 2–4 of activation. At 24 hr,
we infected B cells with I-SceI-expressing retrovirus to induce
DSBs at I-SceI targets (Zarrin et al., 2007). Cells were processed
at day 4 tominimize doublings and potential cellular selection. As
high-titer retroviral infection can impair C-NHEJ (Wang et al.,
2009), we also assayed B cells that express from their Rosa26
locus an I-SceI-glucocorticoid receptor fusion protein (I-SceI-
GR) that can be activated via triamcinolone acetonide (TA) (Fig-
ure 1D; Figures S1D–S1F). The c-myc25xI-SceI cassette was
frequently cut in TA-treated c-myc25xI-SceI/ROSAI-SceI-GR B cells
(Figure S1G).
We employed two HTGTS methods. For the adaptor-PCR
approach (Figure 1E, Siebert et al., 1995), genomic DNA was
fragmented with a frequently cutting restriction enzyme, ligated
to an asymmetric adaptor, and further digested to block amplifi-
cation of germline or unrearranged target alleles. We then per-
formed nested PCR with adaptor- and locus-specific primers.
Depending on the locus-specific PCR primers, one or the other
side of the I-SceI DSB provides the ‘‘bait’’ translocation partner
(Figure 1C), with the ‘‘prey’’ provided by DSBs at other genomic
sites. As a second approach, we employed circularization PCR
(Figure 1E) (Mahowald et al., 2009), in which enzymatically frag-
mented DNA was intramolecularly ligated and digested with
blocking enzymes and nested PCR was performed with locus-
specific primers. Following sequencing of PCR products, we
aligned HTGTS junctions to reference genomes and scripted
filters to remove artifacts from aligned databases. We experi-
mentally controlled for potential background by generating
HTGTS libraries from mixtures of human DNA and mouse DNA
from activated I-SceI-infected c-myc25xI-SceI or DSg12xI-SceI B
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Figure 1. High-Throughput Genomic Translocation Sequencing
(A and B) Circos plots of genome-wide translocation landscape of representative c-myc (A) or IgH (B) HTGTS libraries. Chromosome ideograms comprise the
circumference. Individual translocations are represented as arcs originating from specific I-SceI breaks and terminating at partner site.
(C) Top: a cassette containing either 25 or one I-SceI target(s) was inserted into intron 1 of c-myc (see Figures S1A–S1C). Bottom: a cassette composed of a 0.5 kb
spacer flanked by I-SceI target replaced the IgH Sg1 region. Relative orientation of I-SceI sites is indicated by red arrows. Position of primers for generation and
sequencing HTGTS libraries is shown.
(D) An expression cassette for I-SceI fused to a glucocorticoid receptor (I-SceI-GR) was targeted into Rosa26 (see Figures S1D–S1G). The red fluorescent protein
Tomato (tdT) is coexpressed via an IRES.
(E) Schematic representation of HTGTS methods; left: circularization-PCR, right: adaptor-PCR. See text for details.
(F) Background for HTGTS approaches, calculated as percent of artifactual human:mouse hybrid junctions when human DNA was mixed 1:1 with mouse DNA
from indicated samples.
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cells; junctions fusing mouse and human sequences were less
than 1% of the total (Figure 1F). We identified nearly 150,000
independent junctions from numerous libraries from different
mice (Table S1). Resulting genome-wide junction maps are
shown either as colored dot plots of overall distribution of trans-
location numbers in selected size bins (useful for visualizing hot
spots) or bar plots that compress hot spots and illustrate trans-
location site density. HTGTS yields an average of 1 unique junc-
tion/5 ng of DNA, corresponding to about one junction/1000
genomes. Major findings were reproduced with both HTGTS
methods (e.g., Figure S2A). Moreover, while the largest portion
of data was obtained with c-myc25xI-SceI alleles cut via retroviral
I-SceI, major findings were reproduced via HTGTS from the
c-myc25xI-SceI allele cleaved by I-SceI-GR and the c-myc1xI-SceI
allele cleaved by retroviral I-SceI (Figures S2C and S2D).
Analysis of Genome-wide Translocations
from c-myc DSBs
For HTGTS of c-myc25xI-SceI or c-myc1xI-SceI alleles, we used
primers about 200 bp centromeric to the cassette (Figure 1C)
to detect junctions involving broken ends (BEs) on the 50 side
of c-myc I-SceI DSBs (‘‘50 c-myc-I-SceI BEs’’). Based on
convention, prey sequences joined to 50 c-myc-I-SceI BEs are
in (+) orientation if read from the junction in centromere to telo-
mere direction and in () orientation if read in the opposite direc-
tion (Figures S3A–S3D). Joins in which 50 c-myc-I-SceI BEs are
fused to resected 30 c-myc-I-SceI BEs would be (+) (Figure S3A).
Intrachromosomal joins to DSBs centromeric or telomeric to 50
c-myc-I-SceI BEs would be (+) or () depending on the side of
the second DSB to which they were joined, with potential out-
comes including deletions, inversions, and extrachromosomal
circles (Figures S3B and S3C). Junctions to DSBs on different
chromosomes could be (+) or () and derivative chromosomes
centric or dicentric (Figure S3D). Analyses of over 100,000 inde-
pendent junctions from 50 c-myc-I-SceI BEs fromWT and AID/
backgrounds revealed prey to be distributed widely throughout
the genome with similar general distribution patterns (Figure 2;
Figures S2B, S2E, and S2F). Other than 200 kb downstream of
the bait DSB, intrachromosomal and interchromosomal junc-
tions were evenly distributed into (+) and () orientation (Figure 2;
Figure S3I). This finding implies that extrachromosomal circles
and acentric fragments are represented similarly to other trans-
location classes, suggesting little impact of cellular selection on
junction distribution. The junctions of 50 c-myc-I-SceI BE from
c-myc25xI-SceI, c-myc1xI-SceI, and c-myc25xI-SceI/ROSAI-SceI-GR
models were all consistent with end-joining, and most (75%–
90%) had short junctional MHs (Table S1).
WT and AID/ HTGTS maps for 50 c-myc-I-SceI BEs had
other common features. First, the majority of junctions (75%)
arose from joining 50 c-myc-I-SceI BEs to sequences within 10
kb, with most lying 30 of the breaksite (Figure 3A; Figure S4A).
The density of joins remained relatively high within a region
200 kb telomeric to the breaksite (Figure 3A; Figure S4A).
Notably, most junctions within this 200 kb region, but not
beyond, were in the (+) orientation, consistent with joining to re-
sected 30 c-myc-I-SceI BEs (Figure 3A; Figure S4A). About 15%
of junctions occurred within the region 100 kb centromeric to the
breaksite. As these could not have resulted from resection (due110 Cell 147, 107–119, September 30, 2011 ª2011 Elsevier Inc.to primer removal), they may reflect the known propensity for
joining intrachromosomal DSBs separated at such distances
(Zarrin et al., 2007). Compared with other chromosomes, chr15
had a markedly high density of translocations along its 50 Mb
telomeric portion and also a high density along its centromeric
portion (Figure 2). Many chromosomes had smaller regions of
relatively high or low translocation density, with such overall
patterns conserved between WT and AID/ backgrounds (Fig-
ure 2; Figures S2A–S2F). Finally, although the majority of hot
spots were WT specific, a number were shared between WT
and AID/ backgrounds (see below).
Analysis of HTGTS Libraries from IgH DSBs
For HTGTS of the DSg12xI-SceI alleles, we used primers about
200 bp telomeric to the I-SceI cassette (Figure 1C), allowing
detection of junctions involving BEs on the 50 side of Sg1
I-SceI DSBs (‘‘50 Sg1-I-SceI BEs’’). Intra- and interchromosomal
joins involving 50 Sg1-I-SceI BEs result in (+) or () junctions with
the range of potential chromosomal outcomes including dele-
tions, inversions, extrachromosomal circles, and acentrics
(Figures S3E–S3H). We isolated and analyzed approximately
9000 and 8000 50 Sg1-I-SceI BE junctions from WT and AID/
libraries, respectively (Figures S2G and S2H). Reminiscent of
the 50 c-myc-I-SceI junctions, about 75% of these junctions
were within 10 kb of the breaksite, with a larger proportion on
the 30 side and predominantly in the () orientation, consistent
with joining to resected 30 Sg1-I-SceI BEs (Figures S4B–S4D).
Outside the breaksite region, the general 50 Sg1-I-SceI BE trans-
location patterns resembled those observed for 50 c-myc-I-SceI
BEs, with both (+) and () translocations occurring on all chro-
mosomes (Figures S3J and S2G). Though we analyzed more
limited numbers of 50 Sg1-I-SceI BE junctions (Table S2 and
Figures S2G and S2H), the broader telomeric region of chr12
had a notably large number of hits, and within this region, there
were IgH hot spots in WT, but not AID/, libraries (Figure 3B).
Sm and Sε aremajor targets of AID-initiated DSBs in B cells acti-
vated with aCD40/IL4. Correspondingly, substantial numbers of
50 Sg1-SceI BE junctions fromWT, but not AID/, B cells joined
to either Sm or to S 3, which, respectively, lie approximately 100
kb upstream and downstream of the DSg12xI-SceI cassette (Fig-
ure 3B; Figures S4B–S4D). These findings support the notion
that DSBs separated by 100–200 kb can be joined at high
frequency by general repair mechanisms (Zarrin et al., 2007).
We also observed frequent junctions from WT libraries specifi-
cally within Sg3, which lies about 20 kb upstream of the break-
site, a finding of interest as joining Sg3 to donor Sm DSBs during
CSR in aCD40/IL4-activated B cells occurs at low levels (see
below). Notably, in WT, but not in AID/ libraries, we found
numerous junctions within Sg1 (Figure S4D), which is also
targeted by AID in aCD40/IL4-activated B cells. As Sg1 is
present only on the non-targeted chr12 homolog due to the
DSg12xI-SceI replacement, these findings demonstrate robust
translocation of 50 Sg1-I-SceI BEs to AID-dependent Sg1
DSBs on the homologous chromosome, consistent with trans-
CSR (Reynaud et al., 2005). Finally, while AID deficiency greatly
reduced junctions into S regions, we observed a focal cluster of
five 50 Sg1-I-SceI BE junctions in or near Sm in AID/ DSg12xI-
SceI libraries (Figure 3B; Figure S4C).
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Figure 2. Genome-wide Distribution and Orientation of Translocations from c-myc DSBs
Genome-wide map of translocations originating from the c-myc25xI-SceI cassette (chr15) in aCD40/IL4-activated and I-SceI-infected B cells. Single junctions are
represented by dots located at corresponding chromosomal position. The dot scale is 2Mb. Clusters of translocations are indicated with color codes, as shown in
legend. (+) and () orientation junctions (see Figure S3) are plotted on right and left side of each ideogram, respectively. Hot spots (see Figure 4A) are listed in blue
on top, with notation on the left side of chromosomes to indicate position. Data are from HTGTS libraries from seven different mice. Centromere (Cen) and
telomere (Tel) positions are indicated. See also Figure S2.
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AB
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Figure 3. Distribution of IgH- and c-myc-Proximal
Junctions
(A) Distribution of junctions around chr15 breaksite in the
pooled c-myc25xI-SceI HTGTS library. Top: 10 kb around
breaksite (represented as a split). Middle: 250 kb around
breaksite (represented by red bar); Bottom: 2.5 Mb
around breaksite. (+) and ()-oriented junctions are
plotted on top and bottom of chromosome diagrams,
respectively.
(B and C) Distribution of translocation junctions at IgH
in the pooled DSg12xI-SceI (B) or c-myc25xI-SceI (C) HTGTS
libraries. Translocations in WT (top) and AID/ (bottom) B
cells are shown. Positions of S regions within the 250 kb
IgHCH region are indicated. Color codes are as in Figure 2.
Dot size, position of centromere (red oval) and telomere
(green rectangle), and orientation of the sequencing primer
are indicated. See also Figure S4.Most c-myc Translocation Hot Spots Are Targeted
by AID
To identify 50 c-myc-I-SceI BE translocation hot spots in an unbi-
ased manner, we separated the genome into 250 kb bins and
identified bins containing a statistically significant enrichment
of translocations (Extended Experimental Procedures). This
approach identified 55 hot spots in WT libraries and 15 in AID/
libraries (Table S3; Figure 4A). Among the 43 most significant
hot spots, 39 were in genes and 4 were in intergenic regions.
Of these 43 hot spots, 21 were present at significantly greater
levels in WT versus AID/ backgrounds, and, therefore, classi-
fied as AID dependent; while 9 more were enriched (from 3- to
6-fold) in the WT background and were potentially AID depen-
dent (Table S3; Figure 4A). The other 13 were equally re-
presented between WT and AID/ backgrounds (Table S3;
Figure 4A). Of these 13, two exist in multiple copies (Sfi1 and
miR-715), which may have contributed to their classification as
hot spots (Quinlan et al., 2010; Ira Hall, personal communica-
tion); five reached hot spot significance in only one of the two
backgrounds (Table S3; Figure 4A).112 Cell 147, 107–119, September 30, 2011 ª2011 Elsevier Inc.The Sm, Sg1, and S 3regions, which are tar-
geted for CSR DSBs by aCD40/IL4 treatment,
were by far the strongest AID hot spots for 50
c-myc-I-SceI BEs, with other non-IgH AID-
dependent hot spots ranging from 1% to 10%
of Sm levels (Figure 4A). Translocation specificity
to these three S regions, which together com-
prise less than 20 kb, was striking; there were
only a few junctions in the remainder of the CH
locus, which includes 4 other S regions not sub-
stantially activated by aCD40/IL4 (Figure 3C).
Notably, there was only one 50 c-myc-I-SceI
BE junction with Sg3, even though Sg3 was a
marked hot spot for 50 Sg1-I-SceI BEs. In this
regard, while AID-dependent DSBs in Sg3 likely
are much less frequent than in Sm, Sg1, and S 3
under aCD40/IL4 stimulation conditions, Sg3
DSBs may be favored targets of 50 Sg1-I-SceI
BEs because of linear proximity. Finally, translo-
cations occurred in Sm and Sg1 in AID/B cells
at much lower levels than in WT, but frequently enough to qualify
them as AID-independent hot spots (Figure 4A).
Several top AID SHMor binding targets in activated B cells (Liu
et al., 2008; Yamane et al., 2011) were translocation hot spots for
50 c-myc-I-SceI BEs, including our top 3 non-IgH hot spots (Il4ra,
CD83, and Pim1) and probable AID-dependent translocation
targets (e.g., Pax5 and Rapgef1) (Figure 4A; Table S3). We also
identified other AID-dependent translocation hot spots including
the Aff3, Il21r, and Socs2 genes, and a nonannotated intergenic
transcript on chr4 (Gm12493, Figure 4A; Table S3).Weconfirmed
the ability of such hot spots to translocate to the c-myc25xI-SceI
cassette by direct PCR (Table S4). We conclude that AID not
only binds and mutates numerous non-Ig target genes but also
acts on them to cause DSBs and translocations.
Translocations Genome-wide Frequently Occur Near
Active Transcription Start Sites
To quantify transcription genome-wide, we applied unbiased
global run-on sequencing (GRO-seq; Core et al., 2008) to
aCD40/IL4-activated, I-SceI-infectedBcells.GRO-seqmeasures
elongating Pol II activity and distinguishes transcription on both
strands. For all analyses, we excluded junctions within 1 Mb of
the c-myc breaksite to avoid biases from this dominant class of
junctions. To analyze remaining junctions from WT and AID/
backgrounds, we determined nearest transcription start sites
(TSSs) and divided translocations based on whether or not the
TSShadpromoterproximalactivitybasedonGRO-seq (Extended
Experimental Procedures). Strikingly, both WT and AID/ junc-
tions, when dominant IgH translocations were excluded, showed
a distinct peak that reached a maximum about 300–600 bp on
the sense side of the active TSSs and spanned from about
600 bp on the antisense side to about 1 kb on the sense side
(Figures 4B and 4C). Translocation hot spot genes, including
Il4ra, CD83, Gm12493, Pim1, as well as potential hot spots
including Pax5 and Bcl11a, had a substantial proportion of their
translocations within 1–2 kb regions starting 200–400 bp in the
sense direction from their bidirectional TSSs (Figures 5A and
5B). In one striking example of TSS-proximal translocation target-
ing, there were distinct translocation peaks downstream of the
TSSsof Il4raand Il21r,which lies just 20kbdownstream; yet, there
were no detected translocations into the 30 portion of Il4ra even
though it was highly transcribed (Figure 5A). While lower level
translocations into some AID hot spot genes in AID/ mice had
less correlation with TSS proximity (Figures 5A and 5B), the
overall correlation of translocations and active TSS appeared
similar in WT and AID/ mice (Figures 4B and 4C; Figures S5A
and S5B). Together, our findings indicate a relationship between
active TSSs and AID-dependent and independent transloca-
tions genome-wide. In this context, we did not find a marked
TSS correlation for translocations into nontranscribed genes
(Figures 4B and 4C).
When the dominant IgH hot spots were included in the trans-
location/transcription analyses, the translocation peak shifted
from about 300–600 bp to about 1.5 kb downstream of the
TSS in the sense direction (compare Figures 4B and 4C to
Figures S5C and S5D). In B cells, transcription through Sm initi-
ates from the V(D)J exon and Im exon promoters upstream of
Sm. B cell activation with aCD40/IL4 stimulates CSR between
Sm and Sg1 or S 3by inducing AID and by activating Ig1 and I 3
promoters upstream of Sg1 and S 3. Indeed, most translocations
into germline CH genes in WT aCD40/IL4-activated B cell were
tightly clustered 1-2 kb downstream in the 50 portion of Sm,
Sg1, and S 3, consistent with transcription robustly targeting
AID to S regions (Figure 5C). Finally, AID-independent IgH trans-
locations were scattered more broadly through S and C regions,
suggesting that DSBs that initiate them arise by a different, AID-
independent mechanism of S region instability (Figure 5C).
For 50 c-myc-I-SceI BEs (outside the breaksite region), 55%
of translocations were within genes, whereas genes account for
only 36%of the genome (Table S5). Therefore, we askedwhether
translocations from50 c-myc-I-SceIBEsvariedwithgenedensity.
For this purpose, we compared translocation densities to avail-
able gene density maps and to our GRO-seq transcription
maps of all genes (Figure 6; Figures S6 and S7). Strikingly, trans-
location distribution was highly correlated with gene density and
transcription level. In general, chromosomal regions with highest
transcriptional activity had highest translocation density. In con-
trast, regions with very low or undetectable transcription gener-ally were very low in translocations (Figure 6; Figures S6 and
S7). Notably, we found no obvious regions with high overall
transcription and low translocation levels, supporting a direct
relationship between active transcription and translocation tar-
geting genome-wide. In this context, we observed several robust
AID-independent hot spotpeaks thatwere relatively distant to the
TSS and/or occurred in nonactive genes (Figures 4B and 4C,
asterisks); these hot spots were generated by I-SceI activity at
cryptic endogenous I-SceI sites as discussed next.
HTGTS Libraries Reveal Numerous Cryptic Genomic
I-SceI Target Sites
Eleven AID-independent translocation targets for 50 c-myc-I-
SceI BEswere in genes and twowere in intergenic regions (Table
S3). Eight of these hot spot regions, in which junctions were
tightly clustered, contained potential I-SceI-related sites, many
of which were very near (within 50 bp) or actually contributed
to translocation junctions. These putative cryptic I-SceI sites
had from 1 to 5 divergent nucleotides with respect to the canon-
ical 18 bp target site (Figure 7A).We scanned themouse genome
for potential cryptic I-SceI sites that diverged up to three posi-
tions and identified ten additional sites that map within 400 bp
of one or more 50 c-myc-I-SceI BE translocation junctions (Fig-
ure 7A). In vitro I-SceI digestion of PCR-amplified genomic frag-
ments demonstrated that all eight putative I-SceI targets at hot
spots, and six of seven tested additional putative I-SceI targets,
were bona fide I-SceI substrates (Figures 7A and 7B). We per-
formed direct translocation PCRs with three selected cryptic I-
SceI sites and confirmed I-SceI-dependent translocation to the
c-myc25xI-SceI cassette (Figure 7C). Finally, GRO-seq analyses
showed that five of eight cryptic I-SceI translocation hot spots
were in transcriptionally silent areas and that two I-SceI-gener-
ated hot spots in transcribed genes were distant from the TSS
(Figures 4B and 4C, asterisks; Figures 7D and 7E), highlighting
the distinction between the I-SceI-generated hot spots and
most other genomic translocation hot spots.
DISCUSSION
With HTGTS, we have identified the genome-wide translocations
that emanate from DSBs introduced into c-myc or IgH in acti-
vated B cells. A substantial percentage of these translocations
(80%–90%) join introduced DSBs to sequences on the same
chromosomeproximal to thebreaksite, likely reflecting the strong
preference for C-NHEJ to join DSBs intrachromosomally (Fergu-
son et al., 2000; Zarrin et al., 2007; Mahowald et al., 2009). The
remaining 10%–20% translocate broadly across all chromo-
somes, with translocation density correlating with transcribed
gene density. Translocations are most often near TSSs within
individual genes. Despite c-myc and IgH DSBs translocating
broadly, there are translocation hot spots, with themajority being
generated by cellular AID activity and most of the rest by ectopi-
cally expressed I-SceI activity at cryptic genomic I-SceI target
sequences. Notably, targeted DSBs join at similar levels to both
(+) and () orientations of hot spot sequences, arguing against
a role for cellular selection in their appearance. This finding also
suggests that both sides of hot spot DSBs have similar opportu-
nity to translocate to a DSB on another chromosome.Cell 147, 107–119, September 30, 2011 ª2011 Elsevier Inc. 113
Figure 4. Identification of Specific and General Translocation Hot Spots
(A) Graph representing translocation numbers in frequently hit genes and non-annotated chromosomal regions. Only hot spots withmore than five hits are shown
and are ordered based on frequency of translocations in the pooled c-myc25xI-SceI/WT HTGTS library (top bars). Respective frequencies of translocations in the
pooled c-myc25xI-SceI/AID/ HTGTS library are displayed underneath (bottom bars). Green bars represent frequent hits involving cryptic I-SceI sites. Blue and
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Figure 5. Translocations Preferentially Occur
Near TSSs
WT and AID/ c-myc25xI-SceI HTGTS libraries were
analyzed. In each panel, translocation junctions are in the
first and second rows (WT and AID/ as indicated). The
third and fourth rows represent sense and antisense
nascent RNA signals from GRO-seq. The IgH m, g1, 3
genes are shown in (C), the next most frequently hit hot
spots in (A) and three selected oncogene hot spots in (B).
The transcriptional start site (arrow) is at the bottom of
each panel. The size of each genomic region and number
of junctions in each are shown.The majority of HTGTS junctions from the c-myc I-SceI DSBs
are mediated by end-joining and contain short MHs, reminiscent
of joins in cancer genomes (Stratton et al., 2009) and consistent
with roles for either (or both) C-NHEJ or A-EJ (Zhang et al., 2010).
Recurrence of translocations in cancer genomes is a character-
istic used to consider them as potential oncogenic ‘‘drivers.’’ Our
HTGTS studies establish that many recurrent translocations
form in the absence of selection and, thus, are caused by factors
intrinsic to the translocation mechanism (Wang et al., 2009; Linyellow portions of top bars represent translocations found in c-myc1xI-SceI and c-myc25xI-SceI/RO
human and mouse lymphoma or leukemia are in red. The dashed line represents the cutoff for signifi
(see Table S3).
(B and C) Genome-wide distribution of translocations relative to TSSs. Junctions from c-myc25xI-SceI/W
around chr15 breaksite and IgH S regions) are assigned a distance to the nearest TSS and separate
GRO-seq. Translocation junctions are binned at 100 bp intervals. n represents the number of junction
Asterisks indicate cryptic genomic I-SceI sites. See also Figure S5.
Cell 147, 107–et al., 2009). HTGTS also provides a method
to discover recurrent genomic DSBs, as evi-
denced by ability of HTGTS to find known
DSBs, such as AID-initiated DSBs in S regions,
and previously unrecognized genomic I-SceI
targets. HTGTS should be readily applicable
for genome-wide screens for translocations
and recurrent DSBs in a wide range of cell types.
AID Has a Dominant Role in Targeting
Recurrent Translocations Genome-wide
Prior studies demonstrated that AID binds to
and mutates non-Ig genes (Pasqualucci et al.,
2001; Liu et al., 2008; Yamane et al., 2011). We
find that AID also induces DSBs and transloca-
tions in non-Ig genes with the peak of transloca-
tion junctions spanning the region of the TSS.
Thus, processes closely associated with tran-
scription and, potentially, transcriptional initia-
tion may attract AID activity to these non-Ig
gene targets, consistent with ectopically ex-
pressed AID mutating yeast promoter regions
(Go´mez-Gonza´lez and Aguilera, 2007). IgH
translocation junctions mostly fall 1.5–2 kb
downstream of the activated I region TSSs
within S regions, which are known to be special-
ized AID targets. Thus, transcription through Sregions attracts and focuses AID activity, at least in part via
pausing mechanisms and by generating appropriate DNA
substrates, such as R-loops, for this single-strand DNA-specific
cytidine deaminase (Yu et al., 2003; Pavri and Nussenzweig,
2011; Chaudhuri et al., 2007). Notably, S regions still qualified
as translocation hot spots for 50 c-myc-I-SceI BEs in AID/ B
cells, supporting suggestions that these regions, perhaps via
transcription, may be intrinsically prone to DSBs (Dudley et al.,
2002; Kovalchuk et al., 2007; Unniraman et al., 2004). GivenSAI-SceI-GR libraries, respectively. Genes translocated in
cance over random occurrence for each of the two groups
T (B) or c-myc25xI-SceI/AID/ (C) libraries (excluding 2 Mb
d into ‘‘active’’ and ‘‘inactive’’ promoters as determined by
s within 20 kb (upper panels) or 2 kb (lower panels) of TSS.
119, September 30, 2011 ª2011 Elsevier Inc. 115
Figure 6. Translocations Cluster to Transcribed Regions
Translocation density maps from pooled c-myc25xI-SceI/WT and c-myc25xI-SceI/
AID/ HTGTS libraries are aligned with combined sense and antisense
nascent RNA signals for chr 15, 11, and 17 using the UCSC genome browser.
Chromosome gene densities are displayed below GRO-seq traces. Chromo-
somal orientation from left to right is centromere (C) to telomere (T). See also
Figures S6 and S7.the differential targeting of CSR and SHM (Liu and Schatz, 2009),
application of HTGTS to germinal center (GC) B cells, in which
AID initiates SHM within variable region exons, may reveal novel
AID genomic targets not observed in B cells activated for IgH
CSR in culture, potentially including genes that could contribute
to GC B cell lymphoma (Ku¨ppers and Dalla-Favera, 2001).
A General Role for Transcription and Transcription
Initiation in Targeting Translocations
We find a remarkable genome-wide correlation between tran-
scription and translocations even in AID/ cells, with a peak of
translocation junctions lying near active TSSs. In this context,
while themajority of junctionswere located in the sense transcrip-
tional direction, junctions also occurred at increased levels close
to theTSSon theantisenseside (e.g.,Figures4Band4C;Figure5),
correlating with focal antisense transcription in the immediate
vicinity of active promoters (Core et al., 2008) (Figure 5). Notably,
we observed a number of regions genome-wide that were quite
low in or devoid of translocations and transcription, but few, if
any, that were low in translocations but high in transcription116 Cell 147, 107–119, September 30, 2011 ª2011 Elsevier Inc.(Figure 6). On the other hand, we found that transcription is not
required for high-frequency translocations, since many I-SceI-
dependent hot spots are in nontranscribed regions. Together,
our observations areconsistentwith transcriptionmechanistically
promoting translocations by promoting DSBs. Thus, our findings
strongly support the long-standing notion of a mechanistic link
between transcription, DSBs, and genomic instability (Aguilera,
2002; Haffner et al., 2011; Li and Manley, 2006).
Potential Influences of Genome Organization
on Translocations
The high level of translocations of 50 c-myc-I-SceI BEs to other
sequences alongmuch the length of chr15, while generally corre-
lated with transcription, likely may be further promoted by high
relative proximity of many intrachromosomal regions (Lieber-
man-Aiden et al., 2009). Proximity might also contribute to the
apparently increased frequency of 50 c-myc-I-SceI BEs to certain
regionsof variouschromosomes (e.g., Figure2). In this regard, the
relative frequency of chr15 50 c-myc-I-SceI BE translocations to
theSmandS 3regionsonchr12were only 5 and7 fold less, respec-
tively, than levels of intra-IgH 50 Sg1-I-SceI BE joins to Sm and S 3
(Figure 3C). Thus, even thoughDSBsare rare inc-myc, their trans-
location to IgHwhen they do occur is driven at a high rate by other
mechanistic aspects, most likely proximal position (Wang et al.,
2009). However, we also note that sequences lying in regions
across all chromosomes translocate to DSBs in c-myc on chr15
and IgH in chr12, suggesting the possibility that, in some cases,
DSBs might move into proximity before joining, perhaps during
thecell cycle or viaothermechanisms (e.g.,Dimitrovaet al., 2008).
HTGTS Reveals an Unexpectedly Large Number
of Genomic I-SceI Targets
Our HTGTS studies revealed 18 cryptic genomic I-SceI sites as
translocation targets. There could potentially be more cryptic I-
SceI sites; to find the full spectrum, bait sequences may need
to be introduced into a variety of chromosomal locations to
neutralize position effects. Beyond I-SceI, the HTGTS approach
could readily be extended through the use Zinc finger nucleases
(Ha¨ndel and Cathomen, 2011), meganucleases (Arnould et al.,
2011), or TALENs (Christian et al., 2010) designed to cleave
specific endogenous sites, thereby obviating the need to intro-
duce a cutting site and greatly facilitating the process. The above
three classes of endonucleases are being developed for targeted
gene correction of human mutations in stem cells for gene
therapy. One major concern with such nucleases is relative
activity on the specific target versus off-target activity, with
the latter being difficult to assess. HTGTS provides a means
for identifying off-target DSBs generated by such enzymes, for
assessing ability of such off-target DSBs to translocate, and
for identifying the sequences to which they translocate.
EXPERIMENTAL PROCEDURES
Mouse Strains Utilized
DSg12xI-SceI, c-myc25xI-SceI and AID/ mice were described (Zarrin et al.,
2007; Wang et al., 2009; Muramatsu et al., 2000). c-myc1xI-SceI mice were
generated similarly to c-myc25xI-SceI mice (see Extended Experimental
Procedures). ROSAI-SceI-GR mice were generated by targeting an I-SceI-GR/
IRES-tdTomato expression cassette into Rosa26 (Extended Experimental
BA
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Figure 7. Identification of Cryptic I-SceI Sites in the
Mouse Genome by HTGTS
(A) Cryptic I-SceI site translocation targets. The canonical
I-SceI recognition sequence is on top; nucleotides diver-
gent from the consensus are in red. Chromosomal position
and gene location of each cryptic site are indicated. ‘‘Hits’’
represent total number of unique junctions in a 4 kb region
centered around each site in the pool of all HTGTS libraries
(see also Table S6). In vitro cutting efficiency, evaluated as
in Extended Experimental Procedures, is indicated. NA,
intergenic or not annotated; nd, not determined.
(B) In vitro cutting of PCR products encompassing
indicated cryptic I-SceI sites. C+, positive control: PCR
fragment containing a canonical I-SceI site. U, uncut; I,
I-SceI-digested.
(C) PCR to detect translocations between c-myc25xI-SceI
and cryptic I-SceI sites in Scd2, Dmrt1, and Mmp24
genes. (Top) Position of primers used for PCR amplifica-
tion. (Middle) Average frequency of translocations ± SEM
(Bottom) Number of translocations/105 cells from three
independent c-myc25xI-SceI WT mice.
(D) Transcription in genes containing I-SceI sites deter-
mined by GRO-seq. Translocation junctions are in the first
(AID/) and second (WT) rows; sense and antisense
nascent RNA signals are in the third and fourth rows.
(E) Distance of cryptic I-SceI hot spots from the nearest
TSS in pooled HTGTS libraries from WT and AID/
c-myc25xI-SceI B cells.Procedures). All mice used were heterozygous for modified alleles containing
I-SceI cassettes. The Institutional Animal Care and Use Committee of Chil-
dren’s Hospital, Boston approved all animal work.
Splenic B Cell Purification, Activation in Culture, and Retroviral
Infection
All procedures were performed as previously described (Wang et al., 2009).
c-myc25xI-SceI/ROSAI-SceI-GR B cells were cultured in medium containing
charcoal-stripped serum and I-SceI-GR was activated with 10 mM triamcino-
lone acetate (TA, Sigma).
Generation of HTGTS Libraries
Genomic DNA was digested with HaeIII for c-myc25xI-SceI samples or MspI for
DSg12xI-SceI samples. For adaptor-PCR libraries, an asymmetric adaptor was
ligated to cleaved genomic DNA. Ligation products were incubated with
restriction enzymes chosen to reduce background from germline and unrear-
ranged targeted alleles. Three rounds of nested PCR were performed with
adaptor- and locus-specific primers. For circularization-PCR libraries, HaeIII-
orMspI-digested genomic DNAwas incubated at 1.6 ng/ml to favor intramolec-
ular ligation and samples treatedwith blocking enzymes as above. Two rounds
of nested PCR were performed with primers specific for sequences upstreamCell 147, 107–of the I-SceI cassette. Libraries were sequenced by
Roche-454. See Extended Experimental Procedures for
details.
Data Analysis
Alignment and Filtering
Sequences were aligned to the mouse reference genome
(NCBI37/mm9) with the BLAT program. Custom filters
were used to purge PCR repeats and multiple types of
artifacts including those caused by in vitro ligation and
PCR mispriming.
Hot Spot Identification
Translocations fromWT or AID/ libraries minus those on
chr15 or the IgH locus were pooled. The adjusted genomewas then divided into 250 kb bins and bins containing five or more hits consti-
tuted a hot spot (details in Extended Experimental Procedures).
In Vitro Testing of Putative Cryptic I-SceI Sites
A genomic region encompassing each candidate I-SceI site was PCR-ampli-
fied and 500 ng of purified products were incubated with 5 units of I-SceI for
3 hr. Reactions were separated on agarose gel and relative intensity of uncut
and I-SceI-digested bands calculated with the FluorchemSP program (Alpha
Innotech) (see Extended Experimental Procedures).
PCR Detection of Translocations between c-myc
and Cryptic I-SceI Sites
Translocation junctions between c-myc and cryptic I-SceI targets were PCR-
amplified according to the standard protocol (Wang et al., 2009). Primers and
PCR conditions are detailed in Extended Experimental Procedures.
GRO-Seq
Nuclei were isolated from day 4 aCD40/IL4-stimulated and I-SceI-infected
c-myc25xI-SceI B cells as described (Giallourakis et al., 2010). GRO-seq libraries
were prepared from53 106 cells from two independentmice using adescribed
protocol (Core et al., 2008). Both libraries were sequenced on the Hi-Seq 2000119, September 30, 2011 ª2011 Elsevier Inc. 117
platform with single-end reads and analyzed as described (see Extended
Experimental Procedures). After filtering and alignment, we obtained
34,212,717 reads for library 1 and 15,913,244 reads for library 2. As results
between libraries were highly correlated, we show results only from replicate 1.
ACCESSION NUMBERS
The Gro-Seq data sets are deposited in SRA (http://www.ncbi.nlm.nih.gov/
sra) under accession number SRA049000.
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seven figures, and seven tables and can be found with this article online at
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